Cargando…
Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox
(1) Background: Systemic sclerosis (SSc) is frequently associated with interstitial lung diseases (ILDs). The progressive form of SSc-ILD often limits patient survival. The aim of our study is to evaluate the clinical characteristics and predictors of lung function changes in SSc-ILD patients treate...
Autores principales: | Nagy, Alexandra, Palmer, Erik, Polivka, Lorinc, Eszes, Noemi, Vincze, Krisztina, Barczi, Eniko, Bohacs, Aniko, Tarnoki, Adam Domonkos, Tarnoki, David Laszlo, Nagy, György, Kiss, Emese, Maurovich-Horvat, Pal, Müller, Veronika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962393/ https://www.ncbi.nlm.nih.gov/pubmed/35203643 http://dx.doi.org/10.3390/biomedicines10020434 |
Ejemplares similares
-
Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry
por: Nagy, Tamas, et al.
Publicado: (2022) -
Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
por: Nagy, Alexandra, et al.
Publicado: (2021) -
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
por: Barczi, Eniko, et al.
Publicado: (2020) -
Photon-counting computed tomography in the assessment of rheumatoid arthritis-associated interstitial lung disease: an initial experience
por: Marton, Nikolett, et al.
Publicado: (2023) -
Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease
por: Fesu, Dorottya, et al.
Publicado: (2023)